Subtherapeutic Kitasamycin Promoted Fat Accumulation in the Longissimus Dorsi Muscle in Growing–Finishing Pigs

Kitasamycin (KM), a broad—spectrum macrolide antibiotic, has implications for growth performance and residue in animals and humans. This study aimed to explore the effects of different KM doses on intramuscular fat accumulation, cecal microflora, and short—chain fatty acids (SCFAs) using a growing–f...

Full description

Bibliographic Details
Main Authors: Ge Han, Jie Yu, Jun He, Ping Zheng, Xiangbing Mao, Bing Yu
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/14/7/1057
_version_ 1797212961397276672
author Ge Han
Jie Yu
Jun He
Ping Zheng
Xiangbing Mao
Bing Yu
author_facet Ge Han
Jie Yu
Jun He
Ping Zheng
Xiangbing Mao
Bing Yu
author_sort Ge Han
collection DOAJ
description Kitasamycin (KM), a broad—spectrum macrolide antibiotic, has implications for growth performance and residue in animals and humans. This study aimed to explore the effects of different KM doses on intramuscular fat accumulation, cecal microflora, and short—chain fatty acids (SCFAs) using a growing–finishing pig model. Forty—two pigs were divided into three groups: control, subtherapeutic KM (50 mg/kg, KM50), and therapeutic KM (200 mg/kg, KM200) diets over 8 weeks. KM50 led to increased back fat thickness, fat content in the longissimus dorsi muscle (LM), and elevated plasma total cholesterol (TC) levels (<i>p</i> < 0.05), supported by upregulated lipid synthesis gene expression (<i>Acc1</i>, <i>Fas</i>, <i>Scd1</i>) (<i>p</i> < 0.05) in the LM. KM50 altered cecal microflora, reducing <i>Lactobacillus</i> spp. and <i>Bifidobacterium</i> spp. abundance, while increasing SCFA concentrations (acetic acid, propionic acid, total SCFAs) (<i>p</i> < 0.05). KM200 had minimal effects on intestinal weight and density, with increased apparent digestibility of nutrients. These findings highlight the dose-dependent impact of KM on intramuscular fat deposition. Subtherapeutic KM induced ectopic fat deposition, emphasizing potential risks in disease treatment for humans and animals.
first_indexed 2024-04-24T10:50:42Z
format Article
id doaj.art-2442b58c44834ceaabfb53ba849e555c
institution Directory Open Access Journal
issn 2076-2615
language English
last_indexed 2024-04-24T10:50:42Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj.art-2442b58c44834ceaabfb53ba849e555c2024-04-12T13:14:14ZengMDPI AGAnimals2076-26152024-03-01147105710.3390/ani14071057Subtherapeutic Kitasamycin Promoted Fat Accumulation in the Longissimus Dorsi Muscle in Growing–Finishing PigsGe Han0Jie Yu1Jun He2Ping Zheng3Xiangbing Mao4Bing Yu5Key Laboratory of Animal Disease-Resistant Nutrition and Feed of China Ministry of Agriculture and Rural Affairs, Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, ChinaKey Laboratory of Animal Disease-Resistant Nutrition and Feed of China Ministry of Agriculture and Rural Affairs, Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, ChinaKey Laboratory of Animal Disease-Resistant Nutrition and Feed of China Ministry of Agriculture and Rural Affairs, Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, ChinaKey Laboratory of Animal Disease-Resistant Nutrition and Feed of China Ministry of Agriculture and Rural Affairs, Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, ChinaKey Laboratory of Animal Disease-Resistant Nutrition and Feed of China Ministry of Agriculture and Rural Affairs, Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, ChinaKey Laboratory of Animal Disease-Resistant Nutrition and Feed of China Ministry of Agriculture and Rural Affairs, Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, ChinaKitasamycin (KM), a broad—spectrum macrolide antibiotic, has implications for growth performance and residue in animals and humans. This study aimed to explore the effects of different KM doses on intramuscular fat accumulation, cecal microflora, and short—chain fatty acids (SCFAs) using a growing–finishing pig model. Forty—two pigs were divided into three groups: control, subtherapeutic KM (50 mg/kg, KM50), and therapeutic KM (200 mg/kg, KM200) diets over 8 weeks. KM50 led to increased back fat thickness, fat content in the longissimus dorsi muscle (LM), and elevated plasma total cholesterol (TC) levels (<i>p</i> < 0.05), supported by upregulated lipid synthesis gene expression (<i>Acc1</i>, <i>Fas</i>, <i>Scd1</i>) (<i>p</i> < 0.05) in the LM. KM50 altered cecal microflora, reducing <i>Lactobacillus</i> spp. and <i>Bifidobacterium</i> spp. abundance, while increasing SCFA concentrations (acetic acid, propionic acid, total SCFAs) (<i>p</i> < 0.05). KM200 had minimal effects on intestinal weight and density, with increased apparent digestibility of nutrients. These findings highlight the dose-dependent impact of KM on intramuscular fat deposition. Subtherapeutic KM induced ectopic fat deposition, emphasizing potential risks in disease treatment for humans and animals.https://www.mdpi.com/2076-2615/14/7/1057kitasamycinfat accumulationcecal microfloragrowing finishing pigs
spellingShingle Ge Han
Jie Yu
Jun He
Ping Zheng
Xiangbing Mao
Bing Yu
Subtherapeutic Kitasamycin Promoted Fat Accumulation in the Longissimus Dorsi Muscle in Growing–Finishing Pigs
Animals
kitasamycin
fat accumulation
cecal microflora
growing finishing pigs
title Subtherapeutic Kitasamycin Promoted Fat Accumulation in the Longissimus Dorsi Muscle in Growing–Finishing Pigs
title_full Subtherapeutic Kitasamycin Promoted Fat Accumulation in the Longissimus Dorsi Muscle in Growing–Finishing Pigs
title_fullStr Subtherapeutic Kitasamycin Promoted Fat Accumulation in the Longissimus Dorsi Muscle in Growing–Finishing Pigs
title_full_unstemmed Subtherapeutic Kitasamycin Promoted Fat Accumulation in the Longissimus Dorsi Muscle in Growing–Finishing Pigs
title_short Subtherapeutic Kitasamycin Promoted Fat Accumulation in the Longissimus Dorsi Muscle in Growing–Finishing Pigs
title_sort subtherapeutic kitasamycin promoted fat accumulation in the longissimus dorsi muscle in growing finishing pigs
topic kitasamycin
fat accumulation
cecal microflora
growing finishing pigs
url https://www.mdpi.com/2076-2615/14/7/1057
work_keys_str_mv AT gehan subtherapeutickitasamycinpromotedfataccumulationinthelongissimusdorsimuscleingrowingfinishingpigs
AT jieyu subtherapeutickitasamycinpromotedfataccumulationinthelongissimusdorsimuscleingrowingfinishingpigs
AT junhe subtherapeutickitasamycinpromotedfataccumulationinthelongissimusdorsimuscleingrowingfinishingpigs
AT pingzheng subtherapeutickitasamycinpromotedfataccumulationinthelongissimusdorsimuscleingrowingfinishingpigs
AT xiangbingmao subtherapeutickitasamycinpromotedfataccumulationinthelongissimusdorsimuscleingrowingfinishingpigs
AT bingyu subtherapeutickitasamycinpromotedfataccumulationinthelongissimusdorsimuscleingrowingfinishingpigs